Pros and cons of new oral anticoagulants 喜欢 0 阅读量: 25 作者: KA Bauer 摘要: The availability of new oral anticoagulants (NOACs) targeting either thrombin (dabigatran etexilate) or factor Xa (rivaroxaban and apixaban) for the prevention and treatment of thrombosis has been highly anticipated....
"NOACs", "dabigatran", "rivaroxaban", "apixaban", "edoxaban", "time in therapeutic range", "International Normalized Ratio" "cost-effectiveness", "stroke", "adverse-drug reactions" and "drug-drug interactions", together with the individual names of developing countries as listed by the World ...
As we eagerly await the details of the ARISTOTLE trial to learn how apixaban faired against warfarin, it's a good time to look at the advantages and disadvantages of dabigatran—which along with rivaroxaban and apixaban is vying to dethrone warfarin....
Review New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) Rick H. van Gorp 1,2 and Leon J. Schurgers 1,* Received: 15 May 2015 ; Accepted: 5 November 2015 ; Published: 17 November 2015 1 Department of ...